Literature DB >> 28396028

Prophylactic Indomethacin Revisited.

Jeff Reese1, Elaine L Shelton2, James C Slaughter3, Patrick J McNamara4.   

Abstract

Entities:  

Keywords:  bronchopulmonary dysplasia; ductus arteriosus; indomethacin; prophylaxis

Mesh：

Substances：

Year:  2017        PMID： 28396028      PMCID： PMC5520627          DOI： 10.1016/j.jpeds.2017.03.036

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  47 in total

1.  Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2.

Authors:  F Coceani; P M Olley; E Bodach
Journal:  Prostaglandins       Date:  1975-02

2.  Beagle puppy model of intraventricular hemorrhage: randomized indomethacin prevention trial.

Authors:  L R Ment; W B Stewart; D T Scott; C C Duncan
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

3.  Early indomethacin in patent ductus of the very small premature.

Authors:  E D Burnard; D B Thomas; P Grattan-Smith
Journal:  Aust Paediatr J       Date:  1982-03

4.  The silent ductus arteriosus.

Authors:  R L McGrath; G A McGuinness; G L Way; R R Wolfe; J J Nora; M A Simmons
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

Review 5.  Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

Authors:  Peter W Fowlie; Peter G Davis; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

6.  Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice.

Authors:  Ronald I Clyman; Shampa Saha; Alan Jobe; William Oh
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

7.  A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus.

Authors:  Martin Kluckow; Michele Jeffery; Andy Gill; Nick Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-12-06       Impact factor: 5.747

8.  Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants.

Authors:  D W Thibeault; G C Emmanouilides; R J Nelson; R S Lachman; R M Rosengart; W Oh
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

9.  Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.

Authors:  P Kääpä; P Lanning; M Koivisto
Journal:  Acta Paediatr Scand       Date:  1983-03

10.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406
View more
  8 in total

1.  Diagnosis and Management of Patent Ductus Arteriosus.

Authors:  Maria Gillam-Krakauer; Jeff Reese
Journal:  Neoreviews       Date:  2018-07

Review 2.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

Review 3.  Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis.

Authors:  Souvik Mitra; Courtney E Gardner; Abigale MacLellan; Tim Disher; Danielle M Styranko; Marsha Campbell-Yeo; Stefan Kuhle; Bradley C Johnston; Jon Dorling
Journal:  Cochrane Database Syst Rev       Date:  2022-04-01

4.  Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies.

Authors:  Erik A Jensen; Elizabeth E Foglia; Barbara Schmidt
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

5.  Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.

Authors:  Jonathan L Slaughter; Clifford L Cua; Jennifer L Notestine; Brian K Rivera; Laura Marzec; Erinn M Hade; Nathalie L Maitre; Mark A Klebanoff; Megan Ilgenfritz; Vi T Le; Dennis J Lewandowski; Carl H Backes
Journal:  BMC Pediatr       Date:  2019-09-13       Impact factor: 2.125

Review 6.  Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider.

Authors:  Carl H Backes; Kevin D Hill; Elaine L Shelton; Jonathan L Slaughter; Tamorah R Lewis; Dany E Weisz; May Ling Mah; Shazia Bhombal; Charles V Smith; Patrick J McNamara; William E Benitz; Vidu Garg
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

Review 7.  Application of NPE in the assessment of a patent ductus arteriosus.

Authors:  David van Laere; Bart van Overmeire; Samir Gupta; Afif El-Khuffash; Marilena Savoia; Patrick J McNamara; Christoph E Schwarz; Willem P de Boode
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756

8.  Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants.

Authors:  Ruben Vaidya; Alexander Knee; Yvonne Paris; Rachana Singh
Journal:  J Perinatol       Date:  2020-09-02       Impact factor: 2.521
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.